Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by<sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network

Published:2024-01-11 Issue:2 Volume:65 Page:258-263
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Al Mansour Laure,De Mestier Louis,Haissaguerre Magalie,Afchain Pauline,Hadoux Julien,Lecomte Thierry,Morland David,Cottereau Anne Segolene,De Rycke Ophelie,Tlili Ghoufrane,Tordo Jérémie,Janier Marc,Deville Agathe,Walter Thomas

Publisher

Society of Nuclear Medicine

Reference12 articles.

1. Neuroendocrine tumor disease: an evolving landscape

2. Desmoplastic mesenteric lesions do not respond radiographically to peptide receptor radionuclide therapy;Pelle;J Neuroendocrinol.,2021

3. Evolution of the mesenteric mass in small intestinal neuroendocrine tumours;Blažević;Cancers (Basel).,2021

4. Gastroenteropancreatic neuroendocrine tumors;Cives;CA Cancer J Clin.,2018

5. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to the Patient: Concept and Application of Targeted Radiotherapy in the Paraganglioma Patient;The Journal of Clinical Endocrinology & Metabolism;2024-04-23

2. Lutetium-(177Lu)-oxodotreotide;Reactions Weekly;2024-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP